New Paper- Intranasal VIP safely restores volume to multiple grey matter nuclei in patients with CIRS

New Paper- Intranasal VIP safely restores volume to multiple grey matter nuclei in patients with CIRS

Evidence has accumulated since 2008 that intranasal, topical application of vasoactive intestinal polypeptide (VIP) can be administered safely to patients with a multi-system, multisymptom illness, called chronic inflammatory response syndrome (CIRS), acquired following exposure to biologically p... More»

Featured Products

More Products»

Membership for
Premium Content

  • A section developed specifically for physicians.
  • The Shoemaker Protocol
  • Access to extensive library of academic papers & resources.
  • Products to assist in diagnosis and treatment of biotoxin associated illness.
  • and much more...
Subscribe Now!

Find Certified Physicians

Looking for a Shoemaker Certified Practitioner in your area? Enter your email address below to receive the current list of providers!

Become Certified